NK cells respond to (A) mutations at PC-1 (i.e. 1 residue from the C terminus) or PC-2 in peptides presented by any HLA-C, B*46:01 or B*73:01 molecule, (B) mutations at any position except residue 2 and PC, (C) mutations at PC-1 or PC-2 of 9mers only or (D) mutations at PC-1 or PC-2 in peptides presented by HLA-C1 group molecules only. HLA molecules are considered to be ‘selecting’ if they bind a variant peptide that obeys the definitions (A-D) above, or if they do not bind the wildtype peptide but bind at least one variant peptide; the latter figure is added to give the total frequency of selecting HLAs reported in the table below (see S1 Text for example calculation).